Trial intelligence / Profile preview

Perioperative Lidocaine for GI Recovery in Lumbar Surgery

NCT04922359Unknown

Sponsor
Peking University People's Hospital
Start
Jun 2021
Primary completion
Oct 2022
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial in Digestive tract dysfunction comparing Lidocaine Group with Placebo Group (2 arms). Primary endpoint: First anal exhaust time at Day 0. Status: unknown.

02

Drugs

Lidocaine Hydrochloride Injection, without epinephrine
03

Conditions

Digestive tract dysfunction

Beyond the preview

Go deeper on NCT04922359.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04922359.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call